Soteropoulos Paula

Director at DNTH; Director at QURE; Chief Executive Officer at AKCEA THERAPEUTICS, INC.

Sold, on record
$5.8M
Dollars the filings state
Form 4 sales
20
Latest May 8, 2026
Form 144 notices
2
Proposed sales
Companies
3
Filed as an executive or holder

Companies

Sales by reason

3
Routine
7
Plan not stated
2
No plan
8
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. May 8, 2026Routine

    DNTH

    Sold 100% of their holdings

    $51k599 shares at $85.47

    Filed May 11, 2026Form 4

  2. Mar 31, 2026Routine

    DNTH

    Sold 100% of their holdings

    $48k599 shares at $80.11

    Filed Apr 1, 2026Form 4

  3. Mar 31, 2026Notice

    DNTH

    Filed a notice to sell 1,198 shares

    $95k1,198 shares

    Filed Mar 31, 2026Form 144

  4. Mar 24, 2026Routine

    DNTH

    Sold 100% of their holdings

    $2.2M27,594 shares at $78.05

    Filed Mar 26, 2026Form 4

  5. Mar 24, 2026Notice

    DNTH

    Filed a notice to sell 27,594 shares

    $2.2M27,594 shares

    Filed Mar 24, 2026Form 144

  6. Jun 13, 2024No plan

    QURE

    Sold 9.9% of their holdings

    $11k2,220 shares at $5.14

    Filed Jun 17, 2024Form 4

  7. Jun 16, 2023No plan

    QURE

    Sold 9.2% of their holdings

    $43k2,275 shares at $18.99

    Filed Jun 20, 2023Form 4

  8. Feb 27, 2023Plan not stated

    QURE

    Sold 2.3% of their holdings

    $8k384 shares at $19.97

    Filed Mar 1, 2023Form 4

  9. Jan 18, 2023Unusual

    QURE

    Sold 26.8% of their holdings

    $136k6,000 shares at $22.59

    Filed Jan 20, 2023Form 4

  10. Dec 14, 2022Unusual

    QURE

    Sold 29.3% of their holdings

    $159k6,800 shares at $23.44

    Filed Dec 15, 2022Form 4

10 of 22

Every transaction

Every transaction on a Form 4 or Form 5 by Soteropoulos Paula
TradedFiledStockRoleWhatAmountPriceValueHeld afterSource
Oct 16, 2026Oct 20, 2026RLYBDirectorExercised or settledOption (Right to Buy)3,5620SEC
Oct 16, 2026Oct 20, 2026RLYBDirectorExercised options3,562$2.38$8k6,544SEC
May 21, 2026May 22, 2026DNTHDirectorAwardedStock Option (Right to Buy)6,0906,090SEC
May 8, 2026May 11, 2026DNTHDirectorSold599$85.47$51k0SEC
May 8, 2026May 11, 2026DNTHDirectorExercised or settledStock Option (Right to Buy)5990SEC
May 8, 2026May 11, 2026DNTHDirectorExercised options599$8.44$5k599SEC
Mar 31, 2026Apr 1, 2026DNTHDirectorSold599$80.11$48k0SEC
Mar 31, 2026Apr 1, 2026DNTHDirectorExercised or settledStock Option (Right to Buy)599599SEC
Mar 31, 2026Apr 1, 2026DNTHDirectorExercised options599$8.44$5k599SEC
Mar 24, 2026Mar 26, 2026DNTHDirectorSold27,594$78.05$2.2M0SEC
Mar 24, 2026Mar 26, 2026DNTHDirectorExercised or settledStock Option (Right to Buy)27,5941,198SEC
Mar 24, 2026Mar 26, 2026DNTHDirectorExercised options27,594$8.44$233k27,594SEC
May 22, 2025May 22, 2025DNTHDirectorAwardedStock Option (Right to Buy)12,50012,500SEC
May 13, 2025May 15, 2025RLYBDirectorAwardedOption (Right to Buy)28,50028,500SEC
Jun 13, 2024Jun 17, 2024QUREDirectorSold2,220$5.14$11k20,203SEC
May 23, 2024May 28, 2024DNTHDirectorAwardedStock Option (Right to Buy)11,00011,000SEC
May 15, 2024May 17, 2024RLYBDirectorAwardedOption (Right to Buy)16,50016,500SEC
Sep 11, 2023Sep 13, 2023DNTHDirectorAwardedStock Option (Right to Buy)6,5006,500SEC
Jun 16, 2023Jun 20, 2023QUREDirectorSold2,275$18.99$43k22,423SEC
Jun 13, 2023Jun 20, 2023QUREDirectorAwardedStock Option (Right to Buy)17,06017,060SEC
Jun 13, 2023Jun 20, 2023QUREDirectorAwarded8,70024,698SEC
May 17, 2023May 19, 2023RLYBDirectorAwardedOption (Right to Buy)15,49015,490SEC
Feb 27, 2023Mar 1, 2023QUREDirectorSold384$19.97$8k15,998SEC
Jan 18, 2023Jan 20, 2023QUREDirectorSold6,000$22.59$136k16,382SEC
Jan 18, 2023Jan 20, 2023QUREDirectorExercised or settledStock Option (Right to Buy)6,0002,000SEC
Jan 18, 2023Jan 20, 2023QUREDirectorExercised options6,000$5.37$32k22,382SEC
Dec 14, 2022Dec 15, 2022QUREDirectorSold6,800$23.44$159k16,382SEC
Dec 14, 2022Dec 15, 2022QUREDirectorExercised or settledStock Option (Right to Buy)6,8000SEC
Dec 14, 2022Dec 15, 2022QUREDirectorExercised options6,800$2.37$16k20,182SEC
Nov 29, 2022Dec 1, 2022QUREDirectorSold6,200$25.38$157k16,382SEC
Nov 29, 2022Dec 1, 2022QUREDirectorExercised or settledStock Option (Right to Buy)6,2003,800SEC
Nov 29, 2022Dec 1, 2022QUREDirectorExercised options6,20022,582SEC
Jun 15, 2022Jun 17, 2022QUREDirectorAwardedStock Option (Right to Buy)17,81017,810SEC
Jun 15, 2022Jun 17, 2022QUREDirectorAwarded9,08016,382SEC
May 24, 2022May 26, 2022RLYBDirectorAwardedOption (Right to Buy)13,44013,440SEC
Feb 28, 2022Mar 2, 2022QUREDirectorSold596$16.87$10k7,302SEC
Feb 24, 2022Feb 28, 2022QUREDirectorAwardedStock Option (Right to Buy)2,6452,645SEC
Feb 24, 2022Feb 28, 2022QUREDirectorAwarded1,5347,898SEC
Jan 3, 2022Jan 5, 2022RLYBDirectorAwardedOption (Right to Buy)5,3695,369SEC
Mar 2, 2021Mar 4, 2021QUREDirectorSold504$37.60$19k6,364SEC
Feb 25, 2021Mar 1, 2021QUREDirectorAwardedStock Option (Right to Buy)4,1074,107SEC
Feb 25, 2021Mar 1, 2021QUREDirectorAwarded2,3826,868SEC
Feb 27, 2020Mar 2, 2020QUREDirectorAwardedStock Option (Right to Buy)3,6203,620SEC
Feb 27, 2020Mar 2, 2020QUREDirectorAwarded2,0634,486SEC
Feb 5, 2020Feb 5, 2020QUREDirectorSold2,122$60.95$129k2,423SEC
Jan 28, 2020Jan 30, 2020QUREDirectorSold807$62.19$50k4,545SEC
Jan 7, 2020Jan 8, 2020QUREDirectorSold3,000$72.18$217k5,352SEC
Dec 13, 2019Dec 17, 2019QUREDirectorSold2,000$70.50$141k8,352SEC
Dec 13, 2019Dec 17, 2019QUREDirectorExercised or settledStock Option (Right to Buy)2,0009,000SEC
Dec 13, 2019Dec 17, 2019QUREDirectorExercised options2,000$5.37$11k10,352SEC
Page 1

Sales and notices (22)

Form 144 notices and Form 4 sales by Soteropoulos Paula
Source
May 8, 2026May 11, 2026DNTHDirectorForm 4 sale599$51k100.0%RoutineSEC
Mar 31, 2026Apr 1, 2026DNTHDirectorForm 4 sale599$48k100.0%RoutineSEC
Mar 31, 2026Mar 31, 2026DNTHDirectorForm 144 notice1,198$95kNoticeSEC
Mar 24, 2026Mar 26, 2026DNTHDirectorForm 4 sale27,594$2.2M100.0%RoutineSEC
Mar 24, 2026Mar 24, 2026DNTHDirectorForm 144 notice27,594$2.2MNoticeSEC
Jun 13, 2024Jun 17, 2024QUREDirectorForm 4 sale2,220$11k9.9%No planSEC
Jun 16, 2023Jun 20, 2023QUREDirectorForm 4 sale2,275$43k9.2%No planSEC
Feb 27, 2023Mar 1, 2023QUREDirectorForm 4 sale384$8k2.3%Plan not statedSEC
Jan 18, 2023Jan 20, 2023QUREDirectorForm 4 sale6,000$136k26.8%UnusualSEC
Dec 14, 2022Dec 15, 2022QUREDirectorForm 4 sale6,800$159k29.3%UnusualSEC
Nov 29, 2022Dec 1, 2022QUREDirectorForm 4 sale6,200$157k27.5%UnusualSEC
Feb 28, 2022Mar 2, 2022QUREDirectorForm 4 sale596$10k7.5%Plan not statedSEC
Mar 2, 2021Mar 4, 2021QUREDirectorForm 4 sale504$19k7.3%Plan not statedSEC
Feb 5, 2020Feb 5, 2020QUREDirectorForm 4 sale2,122$129k46.7%UnusualSEC
Jan 28, 2020Jan 30, 2020QUREDirectorForm 4 sale807$50k15.1%Plan not statedSEC
Jan 7, 2020Jan 8, 2020QUREDirectorForm 4 sale3,000$217k35.9%UnusualSEC
Dec 13, 2019Dec 17, 2019QUREDirectorForm 4 sale2,000$141k19.3%Plan not statedSEC
Dec 9, 2019Dec 9, 2019QUREDirectorForm 4 sale11,582$752k58.1%UnusualSEC
Apr 8, 2019Apr 9, 2019AKCEA THERAPEUTICS, INC.Chief Executive OfficerForm 4 sale31,787$1M100.0%UnusualSEC
Mar 6, 2019Mar 7, 2019AKCEA THERAPEUTICS, INC.Chief Executive OfficerForm 4 sale18,386$591k100.0%UnusualSEC
Jan 28, 2019Jan 30, 2019QUREDirectorForm 4 sale1,210$38k5.7%Plan not statedSEC
Jan 29, 2018Jan 31, 2018QUREDirectorForm 4 sale2,878$53k13.8%Plan not statedSEC